Comparison Between Natural Sleep Endoscopy and Drug-induced Sleep Endoscopy in Patients With Obstructive Sleep Apnea
- Conditions
- DyssomniaPhysiological Effects of DrugsSleep Apnea, ObstructiveRespiratory Tract DiseaseHypnotics and SedativesCentral Nervous System DepressantsRespiration DisorderSleep Wake DisordersMidazolamSleep Apnea
- Interventions
- Device: Natural sleep endoscopyDevice: Drug-induced sleep endoscopy
- Registration Number
- NCT04729478
- Lead Sponsor
- ethisch.comite@uza.be
- Brief Summary
Drug-induced sleep endoscopy (DISE) is the most used technique for identifying the obstruction site associated with obstructive sleep apnea (OSA). This is due to the fact that it allows many patients to be examined in a daytime setting. This procedure uses sedative drugs to mimic natural sleep. However, associations with the site of upper airway (UA) collapse during natural sleep remain unclear.
The aim of this explorative study is to identify UA collapse in patients with OSA using endoscopic techniques as well as flow shape characteristics and sound analyses during natural and drug-induced sleep. Furthermore, we want to optimize the measurement set-up of natural sleep endoscopy (NSE).
- Detailed Description
Patients with moderate to severe OSA requiring DISE will be recruited for this prospective study at the outpatient clinic. Patients will undergo a NSE at the sleep lab at night, and a DISE at the operating theatre within three months. Both the NSE and DISE set-up will include gold-standard flow measurements, acoustic analysis and esophageal pressure measurements.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 40
- Diagnosis of OSA with a baseline AHI ≥ 15 per hour based on full polysomnography
- Body mass index (BMI) ≤ 35 kg/m²
- Capability of giving informed consent and willingness to undergo NSE
- Central sleep apnea (defined as CAHI ≥ 30% of total AHI)
- Inability to sleep in a supine position due to a medical condition
- Inability of the patient to understand and/or comply to the study procedures
- Neuromuscular disorders or craniofacial anomalies affecting the UA
- Sedative medication use (opioids and muscle relaxants)
- Active psychiatric disorders (psychotic illness, major depression, anxiety attacks, excessive alcohol or drug use)
- Severe or decompensated cardiac or respiratory diseases
- Medical history of known causes of tiredness by day or severe sleep disruption (insomnia, PLMS, narcolepsy)
- Contra-indications for DISE: i.e. fitness for general anesthesia (ASA>3), allergy to sedative agent(s) and an expected extremely difficult airway
- Pregnancy or willing to become pregnant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Natural sleep Natural sleep endoscopy Natural sleep endoscopy (NSE) OSA patients will be endoscopically evaluated during natural sleep. During NSE additional physiological measurements (flow shape analysis, acoustic analysis of snoring sounds and esophageal pressure measurements) will be carried out. Drug-induced sleep Drug-induced sleep endoscopy Drug-induced sleep endoscopy (DISE) OSA patients will be endoscopically evaluated during drug-induced sleep. During DISE additional physiological measurements (flow shape analysis, acoustic analysis of snoring sounds and esophageal pressure measurements) will be carried out.
- Primary Outcome Measures
Name Time Method Endoscopic Classification System Immediately, during the procedure Comparison of the frequencies of the site, gradation and pattern of upper airway collapse between natural and drug-induced sleep endoscopy.
- Secondary Outcome Measures
Name Time Method Acoustic analysis Immediately, during the procedure Acoustic analyses measured during both natural and drug-induced sleep endoscopy
Flow shape analysis Immediately, during the procedure Several parameters extracted from the flow signal, including negative effort dependence (NED), peak inspiratory flow, etc. measured during both natural and drug-induced sleep endoscopy.
Trial Locations
- Locations (1)
Antwerp University Hospital
🇧🇪Edegem, Antwerp, Belgium